ArticleACS pharmacology & translational science2022

Identification of PDCD2 as a Candidate Target of Andrographolide That Arrests the Tumor Cell Cycle by Human Proteome-Scale Screening.

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.